Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 5,958 shares at $200.00 ($1.2M) on 2021-04-13, disclosed to the SEC on 2021-04-15.
Open-market sale of $1.2M NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.00 | 651 | $130K | 10.9% |
| 2 | $200.00 | 1,833 | $367K | 30.8% |
| 3 | $200.00 | 3,474 | $695K | 58.3% |
| Total | $200.00 avg | 5,958 | $1.2M | 100% |
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |